Kala Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -61 | -66 | ||
EBITDA | -6,714 | -7,409 | -8,060 | -10,286 |
EBIT | -6,783 | -7,472 | -8,121 | -10,352 |
Net Income | -8,175 | -8,950 | -9,579 | -11,807 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -4,667 | -4,676 | -9,251 | -10,857 |
Cash | 51,181 | 49,202 | 54,197 | 48,478 |
Basic Shares | 4,694 | 4,627 | 3,030 | 2,813 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $3,892 | $11,240 |
Gross Profit | -303 | 1,332 | 7,143 | |
EBITDA | -40,983 | -36,082 | -36,696 | -131,957 |
EBIT | -44,294 | -36,385 | -37,556 | -134,225 |
Net Income | -38,511 | -42,199 | -223 | -152,296 |
Net Change In Cash | 0 | 0 | 3,892 | 11,240 |
Free Cash Flow | -29,382 | -28,537 | -79,221 | -109,121 |
Cash | 51,181 | 50,895 | 70,495 | 92,136 |
Basic Shares | 37,960 | 2,432 | 1,520 | 1,304 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-03-31 | -$1.74 |
2024-12-31 | -$1.23 |
2024-09-30 | -$1.93 |
2024-06-30 | -$3.16 |
